ImmunityBio IBRX Stock
ImmunityBio Price Chart
ImmunityBio IBRX Financial and Trading Overview
| ImmunityBio stock price | 2.4 USD |
| Previous Close | 2.55 USD |
| Open | 2.54 USD |
| Bid | 2.42 USD x 100 |
| Ask | 2.43 USD x 100 |
| Day's Range | 2.38 - 2.55 USD |
| 52 Week Range | 1.83 - 7.48 USD |
| Volume | 12.12M USD |
| Avg. Volume | 8.87M USD |
| Market Cap | 2.41B USD |
| Beta (5Y Monthly) | -0.068 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.48 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 10.2 USD |
IBRX Valuation Measures
| Enterprise Value | 3.1B USD |
| Trailing P/E | N/A |
| Forward P/E | -3.857143 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 42.586567 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 54.776 |
| Enterprise Value/EBITDA | -11.523 |
Trading Information
ImmunityBio Stock Price History
| Beta (5Y Monthly) | -0.068 |
| 52-Week Change | -36.25% |
| S&P500 52-Week Change | 15.00% |
| 52 Week High | 7.48 USD |
| 52 Week Low | 1.83 USD |
| 50-Day Moving Average | 2.76 USD |
| 200-Day Moving Average | 3.17 USD |
IBRX Share Statistics
| Avg. Volume (3 month) | 8.87M USD |
| Avg. Daily Volume (10-Days) | 9.64M USD |
| Shares Outstanding | 945.25M |
| Float | 193.56M |
| Short Ratio | 10.42 |
| % Held by Insiders | 69.19% |
| % Held by Institutions | 13.35% |
| Shares Short | 77.07M |
| Short % of Float | 26.47% |
| Short % of Shares Outstanding | 8.14% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2024 |
| Most Recent Quarter (mrq) | June 30, 2025 |
| Next Fiscal Year End | December 31, 2025 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -269.76% |
| Gross Margin | 99.65% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -42.14% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 56.6M USD |
| Revenue Per Share (ttm) | 0.07 USD |
| Quarterly Revenue Growth (yoy) | 2423.90% |
| Gross Profit (ttm) | 56.41M USD |
| EBITDA | -269065984 USD |
| Net Income Avi to Common (ttm) | -367092000 USD |
| Diluted EPS (ttm) | -0.46 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 153.66M USD |
| Total Cash Per Share (mrq) | 0.16 USD |
| Total Debt (mrq) | 842.67M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 4.11 |
| Book Value Per Share (mrq) | -0.623 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -349558016 USD |
| Levered Free Cash Flow (ttm) | -249235872 USD |
Profile of ImmunityBio
| Country | United States |
| State | CA |
| City | San Diego |
| Address | 3530 John Hopkins Court |
| ZIP | 92121 |
| Phone | 844 696 5235 |
| Website | https://immunitybio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 685 |
ImmunityBio, Inc., a commercial stage biotechnology company, develops next-generation therapies that bolster the natural immune systems to defeat cancers and infectious diseases. Its platforms for the development of biologic products and product candidates that include cytokine fusion proteins, DNA and vaccine vectors, and cell therapies. The company's platform has generated first-in-human therapeutic agents that are planned to be studied in clinical trials in liquid and solid tumors. Its lead biologic product candidate includes Anktiva, an FDA-approved immunotherapy in combination with bacillus calmette-guérin (BCG) for the treatment of adult patients with BCG unresponsive non-muscle invasive bladder cancer with carcinoma in situ, with or without papillary tumors. The company has collaboration agreements with National Cancer Institute; Serum Institute of India Private Limited; and BeiGene, Ltd. ImmunityBio, Inc. is based in San Diego, California.
Q&A For ImmunityBio Stock
What is a current IBRX stock price?
ImmunityBio IBRX stock price today per share is 2.4 USD.
How to purchase ImmunityBio stock?
You can buy IBRX shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ImmunityBio?
The stock symbol or ticker of ImmunityBio is IBRX.
Which industry does the ImmunityBio company belong to?
The ImmunityBio industry is Biotechnology.
How many shares does ImmunityBio have in circulation?
The max supply of ImmunityBio shares is 984.97M.
What is ImmunityBio Price to Earnings Ratio (PE Ratio)?
ImmunityBio PE Ratio is now.
What was ImmunityBio earnings per share over the trailing 12 months (TTM)?
ImmunityBio EPS is -0.48 USD over the trailing 12 months.
Which sector does the ImmunityBio company belong to?
The ImmunityBio sector is Healthcare.
ImmunityBio IBRX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 23724.96 USD — |
+0.61
|
9.88B USD — | 23628.82 USD — | 23946.23 USD — | — - | 9.88B USD — |
| US Tech Global Select Market Com NQGS | 11620.1 USD — |
+0.59
|
— — | 11575.56 USD — | 11733.88 USD — | — - | — — |
| Stlmt ID US Tech Biotechnology NBX | 3995.9 USD — |
-4.37
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| US Tech US 700 Small Cap Index NQUS700SC | 2566.34 USD — |
+0.47
|
— — | 2546.3 USD — | 2571.79 USD — | — - | — — |
| US Tech AlphaDEX Multi Cap Growt NQDXUSMLTCG | 3514.71 USD — |
+0.87
|
— — | 3485.13 USD — | 3527.41 USD — | — - | — — |
| US Tech Biotechnology NBI | 5366.46 USD — |
+1.2
|
— — | 5276.16 USD — | 5372.71 USD — | — - | — — |
| US Tech Health Care IXHC | 1115.96 USD — |
+0.87
|
— — | 1099.74 USD — | 1117.62 USD — | — - | — — |
| Horizon Kinetics ISE Wealth Ind RCH | 3688.59 USD — |
+0.39
|
— — | 3653.61 USD — | 3693.99 USD — | — - | — — |
- {{ link.label }} {{link}}